National Center for Toxicological Research*

Size: px
Start display at page:

Download "National Center for Toxicological Research*"

Transcription

1 Cause-of-Death Assignment at the National Center for Toxicological Research* RALPH L. KODELL, 1BOON-NAM BLACKWELL, 2 THOMAS J. BUCCI, 2AND DAVID L. GREENMAN 3 1Division of Biometry and Risk Assessment, 2Pathology Associates, Inc., and 3Office of Scientific Coordination, National Center for Toxicological Research, Jefferson, Arkansas The system for assigning cause of death in animal studies of carcinogenicity at the National Center for Toxicological Research (NCTR) is described. An empirical study of the NCTR s experience with its current cause-of-death assignment system based on selected representative experiments is reported. Issues investigated include the degree of confidence associated with histologic cause-of-death assignment, potential age-, dose-, and sex-related differences in assigned grades of certainty of cause of death, and frequencies of identification of various organ-specific and systemic diagnoses as the cause of death. Implications for ageadjusted statistical tests of carcinogenicity that require cause-of-death data are discussed. Keywords. Rodent bioassay; cancer; neoplasm; tumor; fatal; incidental; context of observation; ageadjusted INTRODUCTION Since its inception, the National Center for Toxicological Research (NCTR) has requested routine assignment of cause of death for all dead and moribund animals examined histologically in carcinogenicity studies. A determination as to whether a particular tumor under consideration was fatal to an animal or was simply an incidental finding at necropsy is important for determining the type of information that an animal contributes to age-adjusted statistical tests for carcinogenic effects (12). Biostatisticians and toxicologic pathologists have discussed the advisability and feasibility of assessing cause of death on a case-by-case basis in animal studies (4, 5, 8, 10, 11, 15, 16). At the EDo, Workshop it was concluded that when data on time-toonset of tumors are not available, a pathologist s assessment as to whether or not an animal died from a tumor, together with an expression of the degree of uncertainty, is useful in statistical analyses of carcinogenicity studies (5). However, the Interdisciplinary Discussion Group on Carcinogenicity Studies indicated that pathologists felt that designating tumors as either fatal or incidental was a difficult judgement that could achieve only partial accuracy * Address correspondence to: Dr. Ralph L. Kodell, Division of Biometry and Risk Assessment, HFT-20, National Center for Toxicological Research, 3900 NCTR Rd., Jefferson, AR (16). Statistical methods have been developed to aid in the interpretation of experiments for which causeof-death data are either lacking or perhaps unreliable ( 1, 7). A number of rodent studies in which cause of death has been determined on a case-by-case basis can be cited (e.g., 3, 4, 9, 13, 14). However, as was recently observed by Ettlin et al. (3), there is still considerable controversy among toxicologic pathologists as to whether or not the cause of death of an individual animal in toxicity and carcinogenicity studies can be established with accuracy. Although not all examining pathologists at the NCTR necessarily agree that cause of death can be assigned reliably, they are willing to provide their best assessment of cause of death in the interest of enhancing the statistical analyses of tumor data. Cause-of-death assignment in the histopathology system at the NCTR was at first very rigid, with no provision for a graded assessment or for equivocation. It has evolved over the years into a more flexible system, which includes 4 grades of certainty (6). The purpose of this paper is to report NCTR s experience with its current cause-of-death assignment system and to evaluate its usefulness for selected representative studies. Issues of interest include the proportions of animals assigned the various grades of certainty of cause of death, potential dose-, sex-, and age-related differences in assigned grades of certainty of cause of death, and frequencies

2 242 TABLE I. - Basic experimental information on 104-wk antihistamine studies. of identification of various organs and diagnoses as the cause of death. METHODS The studies selected for this analysis were 104- wk chronic feeding studies of antihistamines in Fischer 344 rats and B6C3F, mice conducted at the NCTR under the National Toxicology Program (NTP). The test chemicals studied were doxylamine (rats: experiment 406; mice: experiment 407), pyrilamine (rats: experiment 408; mice: experiment 409), and triprolidine (rats: experiment 414; mice: experiment 415). Details of the conduct of these studies are provided in NCTR technical reports for the given experiments. The primary interest here is in the assignment of cause of death to the dead and moribund animals from these studies. Table I presents for each experiment the basic design that gave rise to the dead and moribund animals that were examined. The total number of animals listed reflects the initial number assigned to each experiment, including those killed at both interim and terminal sacrifices. As shown in Table I, there was a much higher proportion of dead/moribund animals in the rat studies than in the mouse studies. For each experiment, all histologic examinations of dead and moribund animals were conducted by a single pathologist. There were three pathologists in all-one assigned to experiment 406; a second one assigned to experiments 407, 414, and 415; and a third one assigned to experiments 408 and 409. The NCTR s current system for grading the certainty of cause of death (cause of morbidity, in the case of moribund animals) is as follows. If a particular neoplasm (or other pathological condition) can be identified by the examining pathologist as the most likely reason for the animal s death or removal, then it is reported as the probable cause of death. At most 1 probable cause of death may be assigned. If a probable cause of death is not identified, then a neoplasm (or other lesion) that is believed to have contributed to an animal s death, but is not thought to be the singular cause, may be reported by the pathologist as a contributory cause. More than 1 contributory cause of death may be assigned to an animal. Lesions that are thought to have had a possible influence on an animal s death or removal may be listed as equivocal. If no neoplasm or other condition is reported as a probable, contributory, or equivocal cause of death for an animal, then that animal is reported as having died from an unknown cause. Although previous automated data collection systems for histopathology at the NCTR supported the routine recording of cause of death, the computerized system presently in use does not support this effort. Consequently, cause of death is recorded by the pathologist in prose in the &dquo;animal notes&dquo; section of the histopathology report. For the usual statistical analysis of tumor data, this information is merged with other histology data in individual animal records prior to analysis. Data preparation for the present analysis began with pathology animal notes reports that were generated for each experiment by a pathology data entry clerk. The clerk highlighted on the printed notes the histologic causes of death of all dead/moribund an-

3 243 TABLE 11. -frequency distribution for grade of certainty of histologic cause of death. - L-V1.J stanus ior cause oi ueam. b Number outside (inside) parentheses is number (percentage) of animals. imals. A statistical assistant tabulated the data from the animal notes report, creating a separate record for each cause of death for each dead/moribund animal. Variables in each record included experiment number; dose level; sex; carcass identification number; pathologist s identification code; and indicators for cause-of-death grade of certainty, causeof-death organ, and cause-of-death diagnosis. The statistical assistant next keyed the tabulated data into a computer file. A third person then checked the accuracy of the computer file by comparing a printout of that file against the printed animal notes. RESULTS For each experiment, Table II gives a frequency distribution of animals according to the grade of certainty of the histologic cause(s) of death. In each of the experiments, a high proportion of causes of death was designated as probable. In all cases for which a probable cause was given, no contributory causes were listed. For the relatively small proportions of animals for which contributory causes were diagnosed, there were always at least 2 such causes given. In only 2 of those cases did an animal have 3 contributory causes assigned. The only animal for which a tumor was reported to be an equivocal cause of death had no other causes listed. In general, this indicates a tendency to assign a single cause of death per animal. The proportion of unknown histologic causes of death was relatively low in all 6 experiments (Table II), but was highest in 3 experiments that were assigned to the same pathologist (pathologist 2; experiments 407, 414, 415). Whereas the proportion of unknown causes of death was lowest for pathologist 1 (experiment 406), the proportion of contributory causes of death was highest for that pathologist. Where a species comparison can be made (for pathologists 2 and 3, Table II), there does not appear to be a difference between species regarding a pathologist s propensity to provide a specific diagnosis for histologic cause of death. In only 1 case was the histologic cause of death listed as equivocal. In these experiments, the examining pathologists did not show a need for this category of grading. Table III provides dose-specific frequency distributions for grade of certainty of histologic cause of death for each experiment. There is little indication that assignment of cause-of-death grade was related to dose of test agent, although for the mice there appears to be a slight tendency for lower proportions of unknown causes of death in the median and high TABLE IIL-Dose-specific frequency distributions for grade of certainty of histologic cause of death. COD stands for cause of death. b Number outside (inside) parentheses is number (percentage) of animals.

4 244 TABLE IV.-Sex-specific frequency distributions for grade of certainty of histologic cause of death. COD stands for cause of death. b Number outside (inside) parentheses is number (percentage) of animals. dose groups compared to the control and low dose groups, while for the rats the opposite is true. Table IV provides similar information on grade for each sex. For these experiments, the grade of certainty of cause of death appears not to have been strongly related to the sex of the animals, although there was slightly greater certainty among male rats than female rats and among female mice than male mice. Table V provides time-specific frequency distributions for grade of certainty of cause of death. The selected time intervals correspond to those used by the NTP for nonparametric analysis of incidental tumor data (2). These data give no consistent indication that grade of certainty of cause of death was related to an animal s time on study. A frequency distribution for both organ-specific and systemic diagnoses that occurred at least twice in the combined 3 rat experiments appears in Table VI. The category of highest frequency in all 3 experiments was mononuclear cell leukemia, a systemic disease involving multiple organs. Approximately 45% of all deaths in the rat experiments were attributed to that disease, with little variation among experiments. Among organ-specific lesions, pituitary gland adenoma was consistently listed with highest frequency. Table VII gives a similar frequency distribution for the 3 mouse experiments. No particular organ-specific diagnosis occurred consistently with high frequency in the mouse experiments, although hepatocellular carcinoma of the liver occurred often in experiment 415. Categories of highest frequency included various types of lymphoma, again a systemic disease involving multiple organs. From 30% to 50% of all deaths in the mouse experiments were ascribed to lymphomas. DISCUSSION In general, these experiments show that NCTR s pathologists were willing to assign a single histologic cause of death per animal. In a high proportion of cases, a probable cause of death was identified. In only 1 case was the histologic cause of death listed as equivocal. Clearly, in these experiments, the examining pathologists did not see a need to have a category between contributory and unknown for as- TABLE V. - Time-specific frequency distributions for grade of certainty of histologic cause of death. COD stands for cause of death. Number outside (inside) parentheses is number (percentage) of animals. &dquo;

5 I ABLE V 1.- l hree rat experiments: trequency distribution tor organ-specl1ic and systemic ftistologic diagnoses occumng at least twice as probable causes of death. 245 signing causes of death. These data indicate that the equivocal category might be superfluous and could be deleted from the cause-of-death assignment system. With respect to the issue of whether or not &dquo;old age&dquo; lesions complicate the interpretation of tumorigenicity assays, in these studies the degree of certainty in assigning cause of death did not appear to be associated in any consistent way with an animal s age. In addition, there was little indication that the assignment of cause-of-death grade was related to either the dose level of the test agent or the TABLE VIL-Three mouse experiments: frequency distribution for organ-specific and systemic histologic diagnoses occurring at least twice as probable causes of death.

6 246 sex of the animal. It is possible that different results would be obtained for strongly carcinogenic test chemicals. The fact that the frequency of unknown histologic causes of death was fairly high in some experiments is not necessarily a problem with respect to statistical tests for carcinogenicity. The important point is whether a particular tumor was the cause of death of an animal. It seems reasonable to assume that any tumor in an animal for which the cause of death is unknown is itself not the cause of death. With respect to contributory and equivocal causes, the issue is not so clear-cut. In the statistical analysis of a particular type of tumor, some analysts might include in the fatal category tumors listed as contributory or equivocal causes of death, while others might treat such tumors as incidental findings. It is not possible to determine with the present data whether the experiments with higher proportions of unknown or contributory histologic causes of death are more or less accurate than those with lower proportions. There is no way to assess the degree of accuracy of the presently reported histologic cause-of-death data, with the available information. However, the propensity for pathologists in these NCTR experiments to assign singular conditions as probable causes of death does support the notion that they could identify with a reasonable degree of confidence a lesion most likely to be responsible for an animal s leaving the experiment. It also supports the feeling expressed by Ettlin et al (3) that agreement among pathologists from different laboratories might be reached on criteria to classify age-related lesions as fatal or incidental. For statistical analyses of tumor data, having cause-of-death data on a case-bycase basis is preferable to a statistician s making a blanket assumption that all tumors of a given type are either fatal or nonfatal. Even when such a blanket assumption by a statistician is justifiable, it can only be made based on the case-by-case experience of toxicologic pathologists. ACKNOWLEDGMENTS The authors thank Becky Rogers and Lisa Wiley for compilation and explanation of the cause-ofdeath data, Richard Allen for assistance with interpreting organ and diagnosis codes, Susan Taylor for tabulation of data and preparation of computer files, and Paula Card for data verification. Also thanks go to Dr. Darnell Jackson for making technical reports available; to Dr. Winslow Sheldon for manuscript review, clarification of terms and procedures, and many helpful recommendations; and to Drs. David Gaylor and James Chen for encouragement. REFERENCES 1. Archer LE and Ryan LM (1989). On the role of causeof-death data in the analysis of rodent tumorigenicity experiments. Appl. Stat. 38: Bailer AJ and Portier CJ (1988). Effects of treatmentinduced mortality and tumor-induced mortality on tests for carcinogenicity in small samples. Biometrics 44: Ettlin RA, Stirnimann P, and Prentice DE (1994). Causes of death in rodent toxicity and carcinogenicity studies. Toxicol. Pathol. 22: Haseman JK, Eustis SL, and Ward JM (1994). Contributing causes of death and the use of this information in the statistical evaluation of tumor data. In: Pathology of the Aging Rat, U Mohr, DL Dungworth, and CC Capen (eds). ILSI Press, Washington, DC, pp Hughes DH, Bruce RD, Hart RW, Fishbein L, Gaylor DW, Smith JM, and Carlton WW (1983). A report on the Workshop on Biological and Statistical Implications of the ED 01 Study and Related Data Bases. Fund. Appl. Toxicol. 3: Kodell RL, Farmer JH, Gaylor DW, and Cameron AM (1982). Influence of cause-of-death assignment on time-to-tumor analyses in animal carcinogenesis studies. J. Natl. Cancer Inst. 69: Lagakos SW, and Louis TA (1988). Use of tumour lethality to interpret tumorigenicity experiments lacking cause-of-death data. Appl. Stat. 37: Lee P (1988). Assumptions in analyses of the bioassay: A statistician s view. In: Carcinogenicity: The Design, Analysis, and Interpretation of Long-Term Animal Studies, HC Grice and JL Ciminera (eds). Springer-Verlag, New York, pp Maita K, Hirano M, Harada T, Mitsumori K, Yoshida A, Takahashi K, Nakashima N, Kitazawa T, Enomoto A, Inui K, and Shirasu Y (1988). Mortality, major cause of moribundity, and spontaneous tumors in CD-1 mice. Toxicol. Pathol. 16: Morgan KT, and Eustis SL (1988). Criteria for classification of neoplasms for pathologists and statisticians. In: Carcinogenicity: The Design, Analysis, and Interpretation of Long-Term Animal Studies, HC Grice and JL Ciminera (eds). Springer-Verlag, New York, pp Park C (1988). Biological assumptions in the bioassay. In: Carcinogenicity: The Design, Analysis, and Interpretation of Long-Term Animal Studies, HC Grice and JL Ciminera (eds). Springer-Verlag, New York, pp Peto R, Pike MC, Day NE, Gray RG, Lee PN, Parish S, Peto J, Richards S, and Wahrendorf J (1980). Guidelines for simple, sensitive significance tests for carcinogenic effects in long-term animal experiments. In: Long-Term and Short-Term Screening Assays for Carcinogens: A Critical Appraisal (IARC Monographs, Supplement 2), R Montesano, H Bertsch, and L Tomatis (eds). International Agency for Research on Cancer, Lyon, pp Shimokawa I, Higami Y, Hubbard GB, McMahan

7 247 CA, Masoro EJ, and Yu BP (1993). Diet and the suitability of the male Fischer 344 rat as a model for aging research. J. Gerontol. 48: B27-B Shimokawa I, Yu BP, Higami Y, Ikeda T, and Masoro EJ (1993). Dietary restriction retards onset but not progression of leukemia in male F344 rats. J. Gerontol. 48: B68-B Shubik P (1983). Objective of carcinogenicity testing. Fund. Appl. Toxicol. 3: Squire RA (1988). Criteria for classifying neoplasms and use of data on nonneoplastic lesions. In: Carcinogenicity: The Design, Analysis, and Interpretation of Long-Term Animal Studies, HC Grice and JL Ciminera (eds). Springer-Verlag, New York, p. 107.

Journal of Statistical Software

Journal of Statistical Software JSS Journal of Statistical Software August 2006, Volume 16, Issue 7. http://www.jstatsoft.org/ A Computational Tool for Testing Dose-related Trend Using an Age-adjusted Bootstrap-based Poly-k Test Hojin

More information

Attribution of Tumor Lethality in the Absence of Cause-of-Death Information Hongshik Ahn 1, Ralph L. Kodell 2, and Hojin Moon 1 1 Department of Applie

Attribution of Tumor Lethality in the Absence of Cause-of-Death Information Hongshik Ahn 1, Ralph L. Kodell 2, and Hojin Moon 1 1 Department of Applie Attribution of Tumor Lethality in the Absence of Cause-of-Death Information Hongshik Ahn 1, Ralph L. Kodell 2, and Hojin Moon 1 1 Department of Applied Mathematics and Statistics State University of New

More information

Toxicol Pathol OnlineFirst, published on July 2, 2009 as doi: / Regulatory Forum

Toxicol Pathol OnlineFirst, published on July 2, 2009 as doi: / Regulatory Forum Toxicol Pathol OnlineFirst, published on July 2, 2009 as doi:10.1177/0192623309339606 Regulatory Forum Toxicologic Pathology, 000: 1-5, 2009 Copyright # 2009 by The Author(s) ISSN: 0192-6233 print / 1533-1601

More information

Experimental Variability within Animal Assays and

Experimental Variability within Animal Assays and FDA Points-to-Consider Documents: The Need for Dietary Control for the Reduction of Experimental Variability within Animal Assays and the Use of Dietary Restriction to Achieve Dietary Control* WILLIAM

More information

Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?

Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens? Regulatory Toxicology and Pharmacology 41 (2005) 128 133 Regulatory Toxicology and Pharmacology www.elsevier.com/locate/yrtph Are tumor incidence rates from chronic bioassays telling us what we need to

More information

Case 3:16-md VC Document Filed 10/28/17 Page 1 of 6 EXHIBIT 101

Case 3:16-md VC Document Filed 10/28/17 Page 1 of 6 EXHIBIT 101 Case 3:16-md-02741-VC Document 655-11 Filed 10/28/17 Page 1 of 6 EXHIBIT 101 Case 3:16-md-02741-VC Document 655-11 Filed 10/28/17 Page 2 of 6 Experimental and Toxicologic Pathology 57 (2006) 377 381 EXPERIMENTAL

More information

Evaluation of Ramazzini Institute Aspartame Studies and EFSA s Assessment

Evaluation of Ramazzini Institute Aspartame Studies and EFSA s Assessment Evaluation of Ramazzini Institute Aspartame Studies and EFSA s Assessment Lisa Y. Lefferts, MSPH Senior Scientist Center for Science in the Public Interest Who is CSPI and What is Our Agenda? CSPI is a

More information

RELATIONSHIP OF BODY-WEIGHT GAIN TO LONGEVITY AND TO RISK OF DEVELOPMENT OF NEPHROPATHY AND NEOPLASIA IN SPRAGUE-DAWLEY RATS

RELATIONSHIP OF BODY-WEIGHT GAIN TO LONGEVITY AND TO RISK OF DEVELOPMENT OF NEPHROPATHY AND NEOPLASIA IN SPRAGUE-DAWLEY RATS Fd Chem. Toxic. Vol., No. 3, pp. 355-361, 1985 Printed in Great Britain. All rights reserved 278-69 15/85 53. +. Copyright 1985 Pergamon Press Ltd RELATIONSHIP OF BODY-WEIGHT GAIN TO LONGEVITY AND TO RISK

More information

of 3-Aminophenol in B6D2F1 Mice

of 3-Aminophenol in B6D2F1 Mice Summary of Drinking Water Carcinogenicity Study of 3-Aminophenol in B6D2F1 Mice July 2012 Japan Bioassay Research Center Japan Industrial Safety and Health Association PREFACE The tests were contracted

More information

IMPURITIES: GUIDELINE FOR RESIDUAL SOLVENTS PDE FOR CUMENE

IMPURITIES: GUIDELINE FOR RESIDUAL SOLVENTS PDE FOR CUMENE INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE DRAFT CONSENSUS GUIDELINE IMPURITIES: GUIDELINE FOR RESIDUAL SOLVENTS Released for

More information

Growth, Body Weight, Survival, and Tumor Trends in F344/N Rats During an Eleven-Year Period"

Growth, Body Weight, Survival, and Tumor Trends in F344/N Rats During an Eleven-Year Period TOXICOLOGIC PATHOLOGY ISSN:O192-6233 Copyright 1990 by the Society of Toxicologic Pathologists Volume 18, Number 1 (Part 1), 1990 Printed in U.S.A. Growth, Body Weight, Survival, and Tumor Trends in F344/N

More information

Glyphosate Cancer Risks and Failures of the Pesticide Regulatory Process

Glyphosate Cancer Risks and Failures of the Pesticide Regulatory Process Glyphosate Cancer Risks and Failures of the Pesticide Regulatory Process Christopher J. Portier, Ph.D. 11 October, 2017 Brussels, Belgium Disclosures The opinions expressed here and the analyses done to

More information

The stability of historical control data for common neoplasms in laboratory rats and the implications for carcinogenic risk assessment

The stability of historical control data for common neoplasms in laboratory rats and the implications for carcinogenic risk assessment Regulatory Toxicology and Pharmacology xxx (2004) xxx xxx Regulatory Toxicology and Pharmacology www.elsevier.com/locate/yrtph The stability of historical control data for common neoplasms in laboratory

More information

A Wistar Rat Strain Prone to Spontaneous Liver Tumor Development: Implications for Carcinogenic Risk Assessment

A Wistar Rat Strain Prone to Spontaneous Liver Tumor Development: Implications for Carcinogenic Risk Assessment Regulatory Toxicology and Pharmacology 36, 86 95 (2002) doi:10.1006/rtph.2002.1567 A Wistar Rat Strain Prone to Spontaneous Liver Tumor Development: Implications for Carcinogenic Risk Assessment Bennard

More information

DOSE SELECTION FOR CARCINOGENICITY STUDIES OF PHARMACEUTICALS *)

DOSE SELECTION FOR CARCINOGENICITY STUDIES OF PHARMACEUTICALS *) DOSE SELECTION FOR CARCINOGENICITY STUDIES OF PHARMACEUTICALS *) Guideline Title Dose Selection for Carcinogenicity Studies of Pharmaceuticals *) Legislative basis Directive 75/318/EEC as amended Date

More information

CANCER HAZARD IDENTIFICATION STRATEGIES PROJECT COMMITTEE

CANCER HAZARD IDENTIFICATION STRATEGIES PROJECT COMMITTEE CANCER HAZARD IDENTIFICATION STRATEGIES PROJECT COMMITTEE Mission The mission of the HESI Cancer Hazard Identification Strategies (CHIS) Project Committee was to consider new strategies that can offer

More information

Conflict of Interest Statement

Conflict of Interest Statement Specific Aspects and Approaches for Regulatory Evaluation of Pharmaceuticals in Two-Year Rodent Carcinogenicity Studies James A. Popp Stratoxon LLC Morgantown, PA Tel: 610.286.7592 popp@stratoxon.com Conflict

More information

Summary of Feed Carcinogenicity Study. of Diphenylamine. in F344 Rats

Summary of Feed Carcinogenicity Study. of Diphenylamine. in F344 Rats Summary of Feed Carcinogenicity Study of Diphenylamine in F344 Rats August 2011 Japan Bioassay Research Center Japan Industrial Safety and Health Association PREFACE The tests were contracted and supported

More information

Beneficial Effects of NTP-2000 Diet on Growth, Survival, and Kidney and Heart Diseases of Fischer 344 Rats in Chronic Studies

Beneficial Effects of NTP-2000 Diet on Growth, Survival, and Kidney and Heart Diseases of Fischer 344 Rats in Chronic Studies TOXICOLOGICAL SCIENCES 63, 245 255 (2001) Copyright 2001 by the Society of Toxicology Beneficial Effects of NTP-2000 Diet on Growth, Survival, and Kidney and Heart Diseases of Fischer 344 Rats in Chronic

More information

Summary of Inhalation Carcinogenicity Study. of Isopropyl Acetate. in F344 Rats

Summary of Inhalation Carcinogenicity Study. of Isopropyl Acetate. in F344 Rats Summary of Inhalation Carcinogenicity Study of Isopropyl Acetate in F344 Rats March 2009 Japan Bioassay Research Center Japan Industrial Safety and Health Association PREFACE The tests were contracted

More information

Regulatory Forum Commentary* Counterpoint: Dose Selection for Tg.rasH2 Mouse Carcinogenicity Studies

Regulatory Forum Commentary* Counterpoint: Dose Selection for Tg.rasH2 Mouse Carcinogenicity Studies Toxicologic Pathology, 43: 621-627, 2015 Copyright # 2015 by The Author(s) ISSN: 0192-6233 print / 1533-1601 online DOI: 10.1177/0192623315587722 Regulatory Forum Commentary* Counterpoint: Dose Selection

More information

HC RED NO Exposure Data H2N~NH-CH2-CH2-0H N02. (d) Solubilty: Soluble in water (0.28% w/w), ethanol and acetone

HC RED NO Exposure Data H2N~NH-CH2-CH2-0H N02. (d) Solubilty: Soluble in water (0.28% w/w), ethanol and acetone HC RED NO. 3 1. Exposure Data 1.1 Chemical and physical data 1.1.1 Synonyms, structural and molecular data Chem. Abstr. Serv Reg. No.: 2871-01-4 Chem. Abstr. Name: 2-(( 4-Amino-2-nitrophenyl)amino )ethanol

More information

Spontaneous Neoplastic Lesions in Aged Sprague-Dawley Rats

Spontaneous Neoplastic Lesions in Aged Sprague-Dawley Rats Exp. Anim. 50(2), 99 103, 2001 Spontaneous Neoplastic Lesions in Aged Sprague-Dawley Rats Motokuni NAKAZAWA, Takeharu TAWARATANI, Hiroshi UCHIMOTO, Akitaka KAWAMINAMI, Makoto UEDA, Akiko UEDA, Yasuhiko

More information

PROSTATIC HYPERPLASIA AND SOCIAL CLASS

PROSTATIC HYPERPLASIA AND SOCIAL CLASS Brit. J. prev. soc. Med. (1964), 18, 157-162 PROSTATIC HYPERPLASIA AND SOCIAL CLASS BY From the Department of Social Medicine, University of Aberdeen It has been known for many years that death rates from

More information

COMMITTEE ON CARCINOGENICITY OF CHEMICALS IN FOOD, CONSUMER PRODUCTS AND THE ENVIRONMENT

COMMITTEE ON CARCINOGENICITY OF CHEMICALS IN FOOD, CONSUMER PRODUCTS AND THE ENVIRONMENT COMMITTEE ON CARCINOGENICITY OF CHEMICALS IN FOOD, CONSUMER PRODUCTS AND THE ENVIRONMENT STATEMENT ON A CARCINOGENICITY STUDY OF ASPARTAME BY THE EUROPEAN RAMAZZINI FOUNDATION COC/06/S2 December 2006 Introduction

More information

EVALUATION DE LA CANCEROGENESE DES MEDICAMENTS QUOI DE NEUF?

EVALUATION DE LA CANCEROGENESE DES MEDICAMENTS QUOI DE NEUF? 1 EVALUATION DE LA CANCEROGENESE DES MEDICAMENTS QUOI DE NEUF? Nigel Roome M.Sc, Ph.D Consultant in Toxicology and Toxicologic Pathology Versailles, France 31.05.2017 nigel.roome@wanadoo.fr 2 Overview

More information

Glyphosate Hazard and Risk Assessment: A Comparison of the Approaches of Two International Agencies

Glyphosate Hazard and Risk Assessment: A Comparison of the Approaches of Two International Agencies Glyphosate Hazard and Risk Assessment: A Comparison of the Approaches of Two International Agencies David A. Eastmond Environmental Toxicology Graduate Program University of California, Riverside Glyphosate

More information

Previous EFSA reports on aspartame available at

Previous EFSA reports on aspartame available at EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS) Consultation Draft scientific opinion on the re evaluation of aspartame as a food additive Comments submitted by Center for Science

More information

APPENDIX AVAILABLE ON THE HEI WEB SITE

APPENDIX AVAILABLE ON THE HEI WEB SITE APPENDIX AVAILABLE ON THE HEI WEB SITE Research Report 166 Advanced Collaborative Emissions Study (ACES) Subchronic Exposure Results: Biologic Responses in Rats and Mice and Assessment of Genotoxicity

More information

DIBROMOACETONITRILE. 1. Exposure Data

DIBROMOACETONITRILE. 1. Exposure Data DIBROMOACETONITRILE Data were last evaluated in IARC (1991). 1. Exposure Data 1.1 Chemical and physical data 1.1.1 Nomenclature Chem. Abstr. Serv. Reg. No.: 3252-43-5 Chem. Abstr. Name: Dibromoacetonitrile

More information

biological agents volume 100 B A review of human carcinogens iarc monographs on the evaluation of carcinogenic risks to humans

biological agents volume 100 B A review of human carcinogens iarc monographs on the evaluation of carcinogenic risks to humans biological agents volume 100 B A review of human carcinogens iarc monographs on the evaluation of carcinogenic risks to humans biological agents volume 100 B A review of human carcinogens This publication

More information

Section H. Case Study: Risk Assessment Issues Associated with Chloroform

Section H. Case Study: Risk Assessment Issues Associated with Chloroform This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this

More information

OECD GUIDELINE FOR TESTING OF CHEMICALS

OECD GUIDELINE FOR TESTING OF CHEMICALS OECD/OCDE 420 Adopted: 17 th December 2001 OECD GUIDELINE FOR TESTING OF CHEMICALS Acute Oral Toxicity Fixed Dose Procedure INTRODUCTION 1. OECD Guidelines for the Testing of Chemicals are periodically

More information

5.15 HEXYTHIAZOX (176)

5.15 HEXYTHIAZOX (176) Hexythiazox 225 5.15 HEXYTHIAZOX (176) TOXICOLOGY Hexythiazox is the ISO approved name for (trans-5-(4-chlorophenyl)-n-cyclohexyl-4-methyl-2-oxo- 3-thiazolidine-carboxamide (CAS No. 78587-05-0). Hexythiazox

More information

Laboratory Animal & Molecular Pathology

Laboratory Animal & Molecular Pathology Laboratory Animal & Molecular Pathology TOXICOLOGIC PATHOLOGY, vol29, no 4, pp 467478,2001 Copyright O 2001 by the Society of Toxicologic Pathology A Retrospective Analysis of Background Lesions and Tissue

More information

Opinion on. Classification of Musk ketone

Opinion on. Classification of Musk ketone EUROPEAN COMMISSION HEALTH & CONSUMER PROTECTION DIRECTORATE-GENERAL Directorate C - Public Health and Risk Assessment C7 - Risk assessment SCIENTIFIC COMMITTEE ON HEALTH AND ENVIRONMENTAL RISKS SCHER

More information

OPINION of the French Agency for Food, Environmental and Occupational Health & Safety

OPINION of the French Agency for Food, Environmental and Occupational Health & Safety Maisons-Alfort, 14 March 2011 The Director General OPINION of the French Agency for Food, Environmental and Occupational Health & Safety on a publication reporting the incidence of cancer in male mice

More information

Tumorigenicity Study of Sodium Erythorbate Administered Orally to Mice

Tumorigenicity Study of Sodium Erythorbate Administered Orally to Mice Hiroshima J. Med. Sci. Vol.38, No.3, 135-139, September, 1989 HJM 38-23 135 Tumorigenicity Study of Sodium Erythorbate Administered Orally to Mice Kouki NA, Hiroshi AKAMZU, Ryozo ETO, Toshihiro NSHDA,

More information

MELAMINE. 1. Exposure Data

MELAMINE. 1. Exposure Data MELAMINE This substance was considered by previous working groups, in 1985 (IARC, 1986) and 1987 (IARC, 1987). Since that time, new data have become available, and these have been incorporated into the

More information

Case 3:16-md VC Document Filed 10/28/17 Page 1 of 38 EXHIBIT 96

Case 3:16-md VC Document Filed 10/28/17 Page 1 of 38 EXHIBIT 96 Case 3:16-md-02741-VC Document 655-6 Filed 10/28/17 Page 1 of 38 EXHIBIT 96 Case 3:16-md-02741-VC Document 655-6 Filed 10/28/17 Page 2 of 38 UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA

More information

WHO/SDE/WSH/04.08/64s. Trihalomethanes in drinking-water Summary statement

WHO/SDE/WSH/04.08/64s. Trihalomethanes in drinking-water Summary statement WHO/SDE/WSH/04.08/64s Trihalomethanes in drinking-water Summary statement World Health Organization September 2004 WHO information products on water, sanitation, hygiene and health can be freely downloaded

More information

Benchmark Dose Modeling Cancer Models. Allen Davis, MSPH Jeff Gift, Ph.D. Jay Zhao, Ph.D. National Center for Environmental Assessment, U.S.

Benchmark Dose Modeling Cancer Models. Allen Davis, MSPH Jeff Gift, Ph.D. Jay Zhao, Ph.D. National Center for Environmental Assessment, U.S. Benchmark Dose Modeling Cancer Models Allen Davis, MSPH Jeff Gift, Ph.D. Jay Zhao, Ph.D. National Center for Environmental Assessment, U.S. EPA Disclaimer The views expressed in this presentation are those

More information

DICHLOROACETONITRILE. 1. Exposure Data

DICHLOROACETONITRILE. 1. Exposure Data DICHLOROACETONITRILE Data were last evaluated in IARC (1991). 1. Exposure Data 1.1 Chemical and physical data 1.1.1 Nomenclature Chem. Abstr. Serv. Reg. No.: 3018-12-0 Chem. Abstr. Name: Dichloroacetonitrile

More information

A case study in risk assessment: aspartame

A case study in risk assessment: aspartame A case study in risk assessment: aspartame Herman B.W.M.Koëter Managing Director,, Brussels, Belgium Thanks to Dr Iona Pratt of the Irish Food Safety Authority for use of a number of the slides in this

More information

THE EFFECT OF DIFFERENT TUMOR GROUPINGS ON FINDINGS OF ANTICARCINOGENIC RESPONSES IN LONG-TERM RODENT BIOASSAYS. Harvard University

THE EFFECT OF DIFFERENT TUMOR GROUPINGS ON FINDINGS OF ANTICARCINOGENIC RESPONSES IN LONG-TERM RODENT BIOASSAYS. Harvard University THE EFFECT OF DIFFERENT TUMOR GROUPINGS ON FINDINGS OF ANTICARCINOGENIC RESPONSES IN LONG-TERM RODENT BIOASSAYS George M. Gray #0, Henry Huang +, Igor Linkov *, Michael Polkanov +, and Richard Wilson +

More information

OECD GUIDELINE FOR TESTING OF CHEMICALS. Proposal for a New DRAFT GUIDELINE 434: Acute Dermal Toxicity Fixed Dose Procedure

OECD GUIDELINE FOR TESTING OF CHEMICALS. Proposal for a New DRAFT GUIDELINE 434: Acute Dermal Toxicity Fixed Dose Procedure OECD GUIDELINE FOR TESTING OF CHEMICLS Proposal for a New DRFT GUIDELINE 434: cute Dermal Toxicity Fixed Dose Procedure DRFT GUIDELINE INTRODUCTION 1. OECD Guidelines for the Testing of Chemicals are periodically

More information

3. Studies of Cancer in Experimental Animals

3. Studies of Cancer in Experimental Animals NEUTRONS 377 3. Studies of Cancer in Experimental Animals Neutrons have been studied in order to compare their carcinogenicity with that of low-let radiations such as X-radiation and γ-radiation, not only

More information

Results of Long-Term Experimental Studies on the Carcinogenicity of Ethylene-bis- Dithiocarbamate (Mancozeb) in Rats

Results of Long-Term Experimental Studies on the Carcinogenicity of Ethylene-bis- Dithiocarbamate (Mancozeb) in Rats Results of Long-Term Experimental Studies on the Carcinogenicity of Ethylene-bis- Dithiocarbamate (Mancozeb) in Rats FIORELLA BELPOGGI, MORANDO SOFFRITTI, MARINA GUARINO, LUCA LAMBERTINI, DANIELA CEVOLANI,

More information

Numbers behind Infographic Assuming Future is around 10 years from now For explanation of scaling see the end of the document CURRENT PREDICTIVE POWER

Numbers behind Infographic Assuming Future is around 10 years from now For explanation of scaling see the end of the document CURRENT PREDICTIVE POWER Numbers behind Infographic Assuming Future is around 10 years from now For explanation of scaling see the end of the document CURRENT PREDICTIVE POWER Human Concordance of animal testing: 60% Calculated:

More information

Implications of the lack of accuracy of the lifetime rodent bioassay for predicting human carcinogenicity

Implications of the lack of accuracy of the lifetime rodent bioassay for predicting human carcinogenicity Regulatory Toxicology and Pharmacology 38 (2003) 52 57 Regulatory Toxicology and Pharmacology www.elsevier.com/locate/yrtph Implications of the lack of accuracy of the lifetime rodent bioassay for predicting

More information

Spontaneous Neoplasms and Survival in Wistar Han Rats: Compilation of Control Group Data. March, 2003

Spontaneous Neoplasms and Survival in Wistar Han Rats: Compilation of Control Group Data. March, 2003 Spontaneous Neoplasms and Survival in Wistar Han Rats: Compilation of Control Group Data March, 2003 Information Prepared by Mary L.A. Giknis Ph.D Charles B. Clifford D.V.M, Ph.D TABLE OF CONTENTS INTRODUCTION...1

More information

Aspartame: the experimental evidence of cancer risks

Aspartame: the experimental evidence of cancer risks Ramazzini Institute Cesare Maltoni Cancer Research Center Aspartame: the experimental evidence of cancer risks Dr. Morando Soffritti, MD International Scientific Conference on Early exposures and childhood

More information

Part 2. Chemical and physical aspects

Part 2. Chemical and physical aspects Part 2. Chemical and physical aspects 12. Chemical and physical aspects: introduction 12.1 Background information used The assessment of the toxicity of drinking-water contaminants has been made on the

More information

3. Studies of Cancer in Experimental Animals

3. Studies of Cancer in Experimental Animals 364 IARC MONOGRAPHS VOLUME 94 3. Studies of Cancer in Experimental Animals 3.1 Pure microcystin-lr (see Table 3.1) 3.1.1 Mouse A group of 13 male ICR mice, 5 weeks of age, received 100 intraperitoneal

More information

Spontaneous Lesions in Aging FVB/N Mice*

Spontaneous Lesions in Aging FVB/N Mice* Spontaneous Lesions in Aging FVB/N Mice* JOEL F. MAHLER, 1 WILLIAM STOKES, 2 PETER C. MANN, 3 MASAYA TAKAOKA, AND ROBERT R. MARONPOT 1 1Laboratory of Experimental Pathology, Environmental Toxicology Program,

More information

ICH Topic S1C(R2) Dose Selection for Carcinogenicity Studies of Pharmaceuticals. Step 5

ICH Topic S1C(R2) Dose Selection for Carcinogenicity Studies of Pharmaceuticals. Step 5 European Medicines Agency October 2008 EMEA/CHMP/ICH/383/1995 ICH Topic S1C(R2) Dose Selection for Carcinogenicity Studies of Pharmaceuticals Step 5 NOTE FOR GUIDANCE ON DOSE SELECTION FOR CARCINOGENICITY

More information

chronic toxicity studies on white oils

chronic toxicity studies on white oils chronic toxicity studies on white oils Prepared for CONCAWE by: A.J. Riley R.A. Priston J.H. Urbanus (Technical Coordinator) Reproduction permitted with due acknowledgement CONCAWE Brussels January 2004

More information

Yours sincerely, C. Guilhem de Seze EFSA Head of Department of Scientific Evaluation of Regulated Products. de Bruijn ECHA Director of Risk Management

Yours sincerely, C. Guilhem de Seze EFSA Head of Department of Scientific Evaluation of Regulated Products. de Bruijn ECHA Director of Risk Management Overall EFSA and ECHA are of the opinion that all the findings on the chronic rodent carcinogenicity studies referred to in your letter have been adequately considered and therefore we see no need for

More information

Summary of Inhalation Carcinogenicity Study. of Tetrachloroethylene. in BDF 1 Mice

Summary of Inhalation Carcinogenicity Study. of Tetrachloroethylene. in BDF 1 Mice Summary of Inhalation Carcinogenicity Study of Tetrachloroethylene in BDF 1 Mice March 1993 Japan Bioassay Laboratory Japan Industrial Safety and Health Association PREFACE The tests were contracted and

More information

Methodology for Statistical Analysis of

Methodology for Statistical Analysis of Environmental Health Perspectives Vol. 68, pp. 5-9, 1986 Methodology for Statistical Analysis of SENCAR Mouse Skin Assay Data by Judy A. Stober* Various response measures and statistical methods appropriate

More information

EPA Health Advisory for PFOA and PFOS Drinking Water

EPA Health Advisory for PFOA and PFOS Drinking Water EPA Health Advisory for PFOA and PFOS Drinking Water David Klein, Ph.D Postdoctoral Fellow Pathology and Laboratory Medicine Brown University David_Klein@brown.edu Outline PFOA Background How did the advisory

More information

Cancerous Contradictions: The Mis-Regulation of Human Carcinogens Based on Animal Data

Cancerous Contradictions: The Mis-Regulation of Human Carcinogens Based on Animal Data The Humane Society Institute for Science and Policy Animal Studies Repository 1-2006 Cancerous Contradictions: The Mis-Regulation of Human Carcinogens Based on Animal Data Andrew Knight Animal Consultants

More information

Expectations for Transgenic Rodent Cancer Bioassay Models

Expectations for Transgenic Rodent Cancer Bioassay Models TOXICOLOGIC PATHOLOGY, vol 29(Suppl.), pp 177 182, 2001 Copyright C 2001 by the Society of Toxicologic Pathology Expectations for Transgenic Rodent Cancer Bioassay Models JOHN ASHBY Syngenta Central Toxicology

More information

DISCUSSION GROUP 3. Mechanism of carcinogenicity. EFSA Scientific Colloquium on Acrylamide carcinogenicity, 22/23 May

DISCUSSION GROUP 3. Mechanism of carcinogenicity. EFSA Scientific Colloquium on Acrylamide carcinogenicity, 22/23 May DISCUSSION GROUP 3 Mechanism of carcinogenicity EFSA Scientific Colloquium on Acrylamide carcinogenicity, 22/23 May 2008 1 1. Review the recent evidence for the mutagenicity and genotoxicity of acrylamide

More information

Aspartame induces lymphomas and leukaemias in rats Aspartame, a leukaemogenic compound

Aspartame induces lymphomas and leukaemias in rats Aspartame, a leukaemogenic compound Aspartame induces lymphomas and leukaemias in rats Aspartame, a leukaemogenic compound 1 European Journal of Oncology, Vol. 10, No. 2, pp. 00-00, 2005 IN PRESS Morando Soffritti, Fiorella Belpoggi, Davide

More information

TR-469 Toxicology and Carcinogenesis Studies of AZT (CAS No ) and AZT/-Interferon A/D B6C3F1 Mice (Gavage Studies)

TR-469 Toxicology and Carcinogenesis Studies of AZT (CAS No ) and AZT/-Interferon A/D B6C3F1 Mice (Gavage Studies) (This document has been reformatted unchanged from the original document except for the bold emphasis editing by Stuart Thomson, Director, the Gaia Research Institute. S.T.) TR-469 Toxicology and Carcinogenesis

More information

ICH Topic S1B Carcinogenicity: Testing for Carcinogenicity of Pharmaceuticals. Step 5

ICH Topic S1B Carcinogenicity: Testing for Carcinogenicity of Pharmaceuticals. Step 5 European Medicines Agency March 1998 CPMP/ICH/299/95 ICH Topic S1B Carcinogenicity: Testing for Carcinogenicity of Pharmaceuticals Step 5 NOTE FOR GUIDANCE ON CARCINOGENICITY: TESTING FOR CARCINOGENICITY

More information

Absence of Uniform Progressive Growth of Long-Term Transplants of Rat Liver Neoplastic Nodules 1,2,3

Absence of Uniform Progressive Growth of Long-Term Transplants of Rat Liver Neoplastic Nodules 1,2,3 Absence of Uniform Progressive Growth of Long-Term Transplants of Rat Liver Neoplastic Nodules 1,2,3 Takaaki Ohmori, 4,5 Kenshi Watanabe, 4,6 and Gary M. Williams 4,7, e, 9 ABSTRACT-Fragments of normal

More information

Metabolite-Based Internal Doses Used in a Risk Assessment of Benzene

Metabolite-Based Internal Doses Used in a Risk Assessment of Benzene Environmental Health Perspectives Vol. 82, pp. 177-184, 1989 Metabolite-Based Internal Doses Used in a Risk Assessment of Benzene by A. John Bailer*t and David G. Hoel* Risk assessments of benzene have

More information

IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. VOLUME 93 Carbon Black, Titanium Dioxide, and Talc

IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. VOLUME 93 Carbon Black, Titanium Dioxide, and Talc WORLD HEALTH ORGANIZATION INTERNATIONAL AGENCY FOR RESEARCH ON CANCER IARC Monographs on the Evaluation of Carcinogenic Risks to Humans VOLUME 93 Carbon Black, Titanium Dioxide, and Talc LYON, FRANCE 2010

More information

Mr. Bruce Allen. Dr. Harvey Clewell.

Mr. Bruce Allen. Dr. Harvey Clewell. Mr. Bruce Allen. Mr. Allen has 27 years of experience related to human and environmental health and safety. He has expertise as a biomathematician involved in risk assessment, modeling, statistical analysis,

More information

INTERNATIONAL CONCIL FOR HARMONISATION OF TECHNICAL REQUIREMENTS FOR PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED GUIDELINE Q3D(R1)

INTERNATIONAL CONCIL FOR HARMONISATION OF TECHNICAL REQUIREMENTS FOR PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED GUIDELINE Q3D(R1) INTERNATIONAL CONCIL FOR HARMONISATION OF TECHNICAL REQUIREMENTS FOR PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED GUIDELINE GUIDELINE FOR ELEMENTAL IMPURITIES (R1) Draft version Endorsed on 18 May 2018

More information

Received: 20 March 2014, Revised: 11 June 2014, Accepted: 11 June 2014 Published online in Wiley Online Library: 25 July 2014

Received: 20 March 2014, Revised: 11 June 2014, Accepted: 11 June 2014 Published online in Wiley Online Library: 25 July 2014 Review Hypothesis Received: 20 March 2014, Revised: 11 June 2014, Accepted: 11 June 2014 Published online in Wiley Online Library: 25 July 2014 (wileyonlinelibrary.com) DOI 10.1002/jat.3045 A proposal

More information

CONTENTS NOTE TO THE READER... 1

CONTENTS NOTE TO THE READER... 1 CONTENTS NOTE TO THE READER.... 1 List of Participants... 3 PREAMBLE... 11 A. GENERAL PRINCIPLES AND PROCEDURES...11 1. Background...11 2. Objective and scope.....................................................................................

More information

A Weight of Evidence Approach to Cancer Assessment. Alan R Boobis Imperial College London

A Weight of Evidence Approach to Cancer Assessment. Alan R Boobis Imperial College London A Weight of Evidence Approach to Cancer Assessment Alan R Boobis Imperial College London a.boobis@imperial.ac.uk Disclosure Statement Member of Board of Trustees of ILSI, Board of Directors of ILSI Europe

More information

PHARMACOLOGY AND TOXICOLOGY MANAGEMENT OF CDER CARCINOGENICITY ASSESSMENT COMMITTEE (CAC) AND EXECUTIVE CAC CONTENTS

PHARMACOLOGY AND TOXICOLOGY MANAGEMENT OF CDER CARCINOGENICITY ASSESSMENT COMMITTEE (CAC) AND EXECUTIVE CAC CONTENTS MANUAL OF POLICIES AND PROCEDURES CENTER FOR DRUG EVALUATION AND RESEARCH MAPP 7412.1 PHARMACOLOGY AND TOXICOLOGY MANAGEMENT OF CDER CARCINOGENICITY ASSESSMENT COMMITTEE (CAC) AND EXECUTIVE CAC CONTENTS

More information

WORLD HEALTH ORGANIZATION INTERNATIONAL AGENCY FOR RESEARCH ON CANCER. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans PREAMBLE

WORLD HEALTH ORGANIZATION INTERNATIONAL AGENCY FOR RESEARCH ON CANCER. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans PREAMBLE WORLD HEALTH ORGANIZATION INTERNATIONAL AGENCY FOR RESEARCH ON CANCER IARC Monographs on the Evaluation of Carcinogenic Risks to Humans PREAMBLE LYON, FRANCE 0 CONTENTS A. GENERAL PRINCIPLES AND PROCEDURES....

More information

Hexavalent Chromium Oral Reference Dose

Hexavalent Chromium Oral Reference Dose Development Support Document Proposed, June Hexavalent Chromium Oral Reference Dose CAS Registry Number: 0-- Prepared by Joseph T. Haney, Jr., M.S. Toxicology Division Office of the Executive Director

More information

Technology appraisal guidance Published: 18 July 2018 nice.org.uk/guidance/ta531

Technology appraisal guidance Published: 18 July 2018 nice.org.uk/guidance/ta531 Pembrolizumab for untreated PD- L1-positive metastatic non-small-cell lung cancer Technology appraisal guidance Published: 18 July 2018 nice.org.uk/guidance/ta531 NICE 2018. All rights reserved. Subject

More information

To: Recipients of JACC 42. HV/mls/JACC 42 corrigendum Brussels, 15 December 2004

To: Recipients of JACC 42. HV/mls/JACC 42 corrigendum Brussels, 15 December 2004 EUROPEAN CENTRE FOR ECOTOXICOLOGY AND TOXICOLOGY OF CHEMICALS AISBL To: Recipients of JACC 42 HV/mls/JACC 42 corrigendum Brussels, 15 December 2004 Dear Sir or Madam, Corrigenda to JACC No. 42 - Tetrafluoroethylene

More information

FINAL. Recommendations for Update to Arsenic Soil CTL Computation. Methodology Focus Group. Contaminated Soils Forum. Prepared by:

FINAL. Recommendations for Update to Arsenic Soil CTL Computation. Methodology Focus Group. Contaminated Soils Forum. Prepared by: A stakeholder body advising the Florida Department of Environmental Protection FINAL Recommendations for Update to Arsenic Soil CTL Computation Prepared by: Methodology Focus Group Contaminated Soils Forum

More information

DANIEL R. DOERGE U.S. Food and Drug Administration National Center for Toxicological Research Jefferson, AR

DANIEL R. DOERGE U.S. Food and Drug Administration National Center for Toxicological Research Jefferson, AR NCTR Research Plan for BPA: Integrating pharmacokinetics in rodent and primate species, rat toxicology studies, human biomonitoring, and PBPK modeling to assess potential human risks from dietary intake

More information

Dose Response Approaches for Nuclear Receptor Mediated Modes of Action Workshop Preliminary Report

Dose Response Approaches for Nuclear Receptor Mediated Modes of Action Workshop Preliminary Report Dose Response Approaches for Nuclear Receptor Mediated Modes of Action Workshop Preliminary Report Workshop Organizing Committee 2 Major Goals of the Workshop Determine whether the biology of nuclear receptors

More information

Combining Risks from Several Tumors Using Markov Chain Monte Carlo

Combining Risks from Several Tumors Using Markov Chain Monte Carlo University of Nebraska - Lincoln DigitalCommons@University of Nebraska - Lincoln U.S. Environmental Protection Agency Papers U.S. Environmental Protection Agency 2009 Combining Risks from Several Tumors

More information

Considerations in Toxicology Study Design and Interpretation: An Overview Gradient Corporation: Lewis, AS; Beyer, LA; Langlois, CJ; Yu, CJ; Wait, AD

Considerations in Toxicology Study Design and Interpretation: An Overview Gradient Corporation: Lewis, AS; Beyer, LA; Langlois, CJ; Yu, CJ; Wait, AD Considerations in Toxicology Study Design and Interpretation: An Overview Gradient Corporation: Lewis, AS; Beyer, LA; Langlois, CJ; Yu, CJ; Wait, AD Introduction The use of animal data to evaluate the

More information

The Effect of Different Tumor Groupings on Findings of Anticarcinogenic Responses in Long-Term Rodent Bioassays

The Effect of Different Tumor Groupings on Findings of Anticarcinogenic Responses in Long-Term Rodent Bioassays Regulatory Toxicology and Pharmacology 36, 139 148 (2002) doi:10.1006/rtph.2001.1524 The Effect of Different Tumor Groupings on Findings of Anticarcinogenic Responses in Long-Term Rodent Bioassays George

More information

Pathology Requirements for Two-year Rodent Studies II. Alternative Approaches*

Pathology Requirements for Two-year Rodent Studies II. Alternative Approaches* SYMPOSIUM Design of Carcino~enicity Studies: Considerations in Pathology interpretation. TOXICOLOGIC PATHOLOGY Vol. If, Xo. 1, 1903 Pathology Requirements for Two-year Rodent Studies II. Alternative Approaches*

More information

Preface: Topics. Cynthia C. Shackelford, DVM, MS, Ph.D. Experimental Pathology Laboratories, Inc. Research Triangle Park, NC

Preface: Topics. Cynthia C. Shackelford, DVM, MS, Ph.D. Experimental Pathology Laboratories, Inc. Research Triangle Park, NC Cynthia C. Shackelford, DVM, MS, Ph.D. Experimental Pathology Laboratories, Inc. Research Triangle Park, NC EPL Preface: Reports are written to convey information concerning the pathologic findings in

More information

SUPPLEMENTARY INFORMATION GENOTOXICITY. In vitro Genotoxicity Studies

SUPPLEMENTARY INFORMATION GENOTOXICITY. In vitro Genotoxicity Studies SUPPLEMENTARY INFORMATION GENOTOXICITY In vitro Genotoxicity Studies The in vitro immortalisation (IVIM) assay relies on the induction of a survival advantage by insertional activation of cellular proto-oncogenes,

More information

Radiofrequency Radiation

Radiofrequency Radiation Radiofrequency Radiation A Possible Human Carcinogen? Ron Melnick Retired Toxicologist NTP/NIEHS Expert Forum: Wireless Radiation and Human Health Hebrew University Medical School January 23-26, 2017 IARC

More information

APR RE: Docket Numbers 94P-0420 and FDA-2008-P /CP. Dear Dr. Epstein:

APR RE: Docket Numbers 94P-0420 and FDA-2008-P /CP. Dear Dr. Epstein: DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service Food and Drug Administration College Park, MD 20740 APR 1-2014 SamuelS. Epstein, M.D. Cancer Prevention Coalition University of Illinois at

More information

Comments DRAFT Preamble to the IARC Monograph. Health and Safety Department International Union, UAW 8000 East Jefferson Avenue Detroit, MI 48214

Comments DRAFT Preamble to the IARC Monograph. Health and Safety Department International Union, UAW 8000 East Jefferson Avenue Detroit, MI 48214 Comments DRAFT Preamble to the IARC Monograph Health and Safety Department International Union, UAW 8000 East Jefferson Avenue Detroit, MI 48214 The International Union, UAW affirms the importance of the

More information

TOXICITY DATA (continued): KETOCONAZOLE (continued): TDLo (Oral-Rat) 1760 mg/kg: female 1-21 day(s) after conception: Reproductive: Maternal Effects: other effects; Fertility: post-implantation mortality

More information

5. Summary of Data Reported and Evaluation

5. Summary of Data Reported and Evaluation 5. Summary of Data Reported and Evaluation 5.1 Exposure data Static electric and magnetic fields arise from both natural and man-made sources, whereas electric and magnetic fields in the extremely low-frequency

More information

ORIGIN OF LEUKEMIC CELLS IN MOUSE LEUKEMIA INDUCED BY N-BUTYLNITROSOUREA*1. ed by cytotoxicity tests. Cells from leukemia without thymus involvement

ORIGIN OF LEUKEMIC CELLS IN MOUSE LEUKEMIA INDUCED BY N-BUTYLNITROSOUREA*1. ed by cytotoxicity tests. Cells from leukemia without thymus involvement [Gann, 66, 37-42; February, 1975] ORIGIN OF LEUKEMIC CELLS IN MOUSE LEUKEMIA INDUCED BY N-BUTYLNITROSOUREA*1 Hayase SHISA, Yasue MATSUDAIRA, Hiroshi HIAI, and Yasuaki NISHIZUKA Laboratory of Experimental

More information

Considerations on the statistical methods used to assess carcinogenicity studies of pesticides with emphasis on glyphosate

Considerations on the statistical methods used to assess carcinogenicity studies of pesticides with emphasis on glyphosate Considerations on the statistical methods used to assess carcinogenicity studies of pesticides with emphasis on glyphosate by Peter Clausing, PAN Germany Hamburg - April 2016 Introduction Much of the controversy

More information

Survival Rates of Childhood Cancer Patients in Osaka, Japan

Survival Rates of Childhood Cancer Patients in Osaka, Japan Jpn J Clin Oncol 2004;34(1)50 54 Epidemiology Note Survival Rates of Childhood Cancer Patients in Osaka, Japan Wakiko Ajiki, Hideaki Tsukuma and Akira Oshima Department of Cancer Control and Statistics,

More information

IPCS Conceptual Framework for Evaluating a Mode of Action for Chemical Carcinogenesis

IPCS Conceptual Framework for Evaluating a Mode of Action for Chemical Carcinogenesis Regulatory Toxicology and Pharmacology 34, 146 152 (2001) doi:10.1006/rtph.2001.1493, available online at http://www.idealibrary.com on IPCS Conceptual Framework for Evaluating a Mode of Action for Chemical

More information

LOW DOSES OF RADIATION REDUCE RISK IN VIVO

LOW DOSES OF RADIATION REDUCE RISK IN VIVO Dose-Response: An International Journal Volume 5 Issue 1 ADAPTIVE BIOLOGICAL RESPONSES FOLLOWING EXPOSURES TO IONIZING RADIATION Article 4 3-2007 LOW DOSES OF RADIATION REDUCE RISK IN VIVO REJ Mitchel

More information

Determining Disease Causality From Experimental Toxicology Studies

Determining Disease Causality From Experimental Toxicology Studies Journal of Law and Policy Volume 15 Issue 1 Article 5 2007 Determining Disease Causality From Experimental Toxicology Studies Ronald L. Melnick John R. Bucher Follow this and additional works at: http://brooklynworks.brooklaw.edu/jlp

More information